MedTrace Logo

Clinical Study on the Effect of a Synbiotic on Body Fat Mass

NCT04754464 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 120

Last updated 2022-06-01

No results posted yet for this study

Summary

In this trial the effect of a synbiotic consisting of the three different strains of Lactobacillus fermentum and acacia gum (gum arabic) on body fat mass, body weight, long-term glycemia, insulin resistance and other risk factors for CVD and diabetes in overweight type 2 diabetics is investigated.

Conditions

Interventions

DIETARY_SUPPLEMENT

synbiotic

Consumption of 6 g powder consisting of the strains Lactobacillus fermentum K7-Lb1, L. fermentum K8-Lb1, L. fermentum K11-Lb3, acacia gum (gum arabic), maltodextrin, sucralose and flavour twice a day resolved in water

DIETARY_SUPPLEMENT

microcrystalline cellulose

Consumption of 6 g powder containing microcrystalline cellulose, maltodextrin , sucralose and flavour twice a day, resolved in water

Sponsors & Collaborators

  • Clinical Research Center Kiel GmbH

    collaborator OTHER

  • Slimbiotics GmbH

    lead INDUSTRY

Principal Investigators

  • Christiane Laue, Dr. med. · Clinical Research Center Kiel

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-05-13
Primary Completion
2021-09-15
Completion
2022-05-31

Countries

  • Austria
  • Germany

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04754464 on ClinicalTrials.gov